Navigation Links
Vermont Youth Named National Epilepsy Spokesperson
Date:3/14/2008

Jessica Fennell to Visit Washington, D.C., and Meet with Elected Officials

WASHINGTON, March 14 /PRNewswire-USNewswire/ -- Jessica Fennell of Jeffersonville, Vt., will travel to Washington, D.C., this April 1 to meet with congressional leaders and gain their support for restoration of the Americans with Disabilities Act, support for epilepsy public health programs and more research toward a cure for epilepsy.

Fennell, 16, is one of 50 young people with epilepsy participating in Kids Speak Up!, a national program coordinated by the Epilepsy Foundation with support from Abbott. The program rallies young ambassadors with epilepsy between the ages of 7 and 16 to advocate for the more than 3 million Americans living with the condition.

"Jessica was selected to participate in Kids Speak Up! to represent the approximately 350,000 children under the age of 17 who are affected by the condition. She is an ideal candidate because of her desire to achieve her goals despite her challenges. Jessica's courage is an inspiration to us all," said Eric R. Hargis, President and CEO of the Epilepsy Foundation.

This year's participants are a diverse group ranging from those with controlled seizures to those who are massively affected by their epilepsy.

Despite their individual challenges, the kids enjoy doing ordinary things, so when they come to D.C., besides meeting with their leaders, they will be treated to a magic show featuring award-winning magician Bradley Fields and meet Mighty Mike Simmel, an entertainment basketball player of the world famous Harlem Wizards. Simmel, who also has epilepsy, inspires young people to follow their dreams despite their obstacles.

Epilepsy is the most common neurological condition in children and each year approximately 45,000 children under age 17 are diagnosed with the disorder. Despite modern therapy, about one million people in the U.S. continue to experience seizures or significant sid
'/>"/>

SOURCE Epilepsy Foundation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Vermont Requires Reporting of NQF Serious Reportable Events
2. More than two-thirds of sexually active NYC youth use condoms, but other forms of birth control lag
3. Study documents rapid increase in youth bipolar disorder diagnoses
4. Rates of bipolar diagnosis in youth rapidly climbing, treatment patterns similar to adults
5. Youth Drug Use at a Five Year Low, New Survey Shows
6. Jump in Youth Suicide Prompts National Childrens Charity KidsPeace to Issue Tips on Prevention, Warning Signs
7. ARIZONA METH PROJECT Unveils Arizonas Anti-Meth Youth Pledge and Kicks Off Phase Two of Public Awareness Campaign
8. $8,000 Winning Bids at Governors Livestock Auction to Benefit College-Bound Youth and Homeless
9. Nourishment Is Essential to a Youthful Appearance. Time to Feed Your Face with Serum_G
10. Prime Access Creates Groundbreaking Ads Targeting Urban Teens for the White Houses National Youth Anti-Drug Media Campaign
11. Safe Blood for Africa Foundations African Club 25 Greatly Reducing HIV Infections in African Youth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...ert Pathologists Discuss the Latest Developments i...RTHFIELD, Ill., Sept. 5 /PRNewswire-USNewswire/ --...point. Molecular testing and the promise,of person...reated. Digital,slides and other imaging technolog...lege of American Pathologists is taking a leadersh...
(Date:9/5/2008)...hers explain how theoretical ,anti-cloak, could br...pt. 5 (HealthDay News) -- Just in case someone dev...cientists say they know how to uncloak the objects... Optics Express , certain materials underneath an ...o be seen again. , Researchers at Shanghai Jiao...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- Speake...y in support of the aims of the "Stand,Up to Cance... "There is not a person in our country who has no...r kills 565,000 Americans annually, and each,year ...ricans must work,together to make eradicating the ...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- U.S. c...r relief to Cuban victims of Hurricane,Gustav, whi...s., (http://www.PanAmericanRelief.org ), "Donatio...perately need,after this natural disaster," says M... Initiative at the Pan American Development Founda...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:Cuban Disaster Relief Donations Sought in the Wake of Hurricane Gustav 2
...mab) drug is found to be useful in treating patien... by the European Medicines Agency (EMEA) for use i...rrent drugs//. Xolair can be used in the treatment...effects of the new drug on long time usage has to ...
... suggests that the melanocortin system is an impor...al neuronal plasticity observed after chronic morp... is accompanied by the development of morphine tol...ms associated with opiate treatment. Possible modu...
...m Italy have designed a closed circuit, where Umbi...n are performed, in order to reduce the contaminat...n//. Their findings appear in the journal Blood C...le online 19 August 2005)Umbilical cord blood is a...
...cal tourism is currently the buzz word of Indian h...g from USA and Canada for niche high cost orthoped...e replacement. // The fact that surgeries by many... and they have wide experience helps to win over t...
Other Medicine News:Health News:Inhibition of morphine tolerance by spinal melanocortin receptor blockade 2Health News:A Novel System For Clinical Banking Of Umbilical Cord Blood 2Health News:India - Favored Orthopedics Surgery Destination 2Health News:India - Favored Orthopedics Surgery Destination 3
(Date:9/5/2008)...lif., Sept. 5 /- SARcode,Co...cule LFA-1 inhibitors,to treat inflammatory diseas...S) today announced SARcode,s initiation of a Phase...t candidate for T-cell mediated ophthalmic,disease...ement providing,SARcode with an exclusive license ...
(Date:9/4/2008)...ept. 4 /- Cytopia Limited (ASX:,CYT) ...r its Phase Ib/II,study of CYT997, the company,s n...ents with an aggressive form of brain cancer known...cal trial is the first Phase II efficacy study in ...ompany and the second in its,suite of Phase II stu...
(Date:9/4/2008)...Man(R) real-time PCR testing for the diagnostic ...alif., Sept. 4 /- The U.S. Food & Dru...S(R) TaqMan(R) HBV Test,the first assay for quant...,The test uses Roche,s real-time PCR technology to... patient,s blood. Doctors may use viral load,testi...
(Date:9/4/2008)... 4 /- Southern Research Institute,tod...h (NIH) has selected,the organization to participa...roduction Center Network (MLPCN). The MLPCN -- a c...lecular Libraries Program which is,designed to ben... the human,genome and validate future targets for ...
Breaking Medicine Technology:SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases 2SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases 3Cytopia Commences Second Phase II Study in Brain Cancer 2Cytopia Commences Second Phase II Study in Brain Cancer 3FDA Approves First Hepatitis B Viral Load Test 2FDA Approves First Hepatitis B Viral Load Test 3Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 2Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 3Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 4Coalition of Caregivers Warns Congress of Danger to Oldest U S Seniors if Medicare Slashed 5228 1Coalition of Caregivers Warns Congress of Danger to Oldest U S Seniors if Medicare Slashed 5228 2Coalition of Caregivers Warns Congress of Danger to Oldest U S Seniors if Medicare Slashed 5228 3Coalition of Caregivers Warns Congress of Danger to Oldest U S Seniors if Medicare Slashed 5228 4New ActivePure Technology Proven To Reduce Exposure to Methicillin Resistant Staphylococcus Aureus 28MRSA 29 1653 1New ActivePure Technology Proven To Reduce Exposure to Methicillin Resistant Staphylococcus Aureus 28MRSA 29 1653 2Vasogen to Webcast Presentations at Three Upcoming Healthcare Conferences 1649 1Vasogen to Webcast Presentations at Three Upcoming Healthcare Conferences 1649 2Vasogen to Webcast Presentations at Three Upcoming Healthcare Conferences 1649 3Mayo Clinic Study Shows Drug Could Effectively Treat Prevent the Spread of Breast Cancer 720 1Mayo Clinic Study Shows Drug Could Effectively Treat Prevent the Spread of Breast Cancer 720 2Mayo Clinic Study Shows Drug Could Effectively Treat Prevent the Spread of Breast Cancer 720 3
...Abbott,s Bioabsorbable Stent Technology Holds Prom...icians Treating Patients,with Coronary Artery Dise...-FirstCall/ --,Abbott today announced positive res... evaluating the overall safety and performance,of ... for the,treatment of coronary artery disease. Six...
...Initial Analysis Shows Statistically Significant C... ALTO, Calif., March 26, 2007 /PRNewswire-FirstCal... positive initial,results from its Phase IIa clini...zophrenic patients with acute agitation. The 10 mg...inical trial,which was a statistically-significan...
Other Medicine Technology:Abbott Announces Positive Six-Month Results From the World's First,Clinical Trial of a Fully Bioabsorbable Drug-Eluting Coronary Stent 2Abbott Announces Positive Six-Month Results From the World's First,Clinical Trial of a Fully Bioabsorbable Drug-Eluting Coronary Stent 3Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating,Schizophrenic Patients With Acute Agitation 2Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating,Schizophrenic Patients With Acute Agitation 3Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating,Schizophrenic Patients With Acute Agitation 4Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating,Schizophrenic Patients With Acute Agitation 5Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating,Schizophrenic Patients With Acute Agitation 6
...nd medium volume laboratories, as well as specialt...simplicity and flexibility needed to respond to mu... the Elecsys 1010 system enables operators to hand...e testing without sacrificing ease of operation or...
The Dimension RxL Max is an integrated chemistry system and is the most powerful and technologically advanced Dimension analyze with new standard for excellence in clinical diagnostics. Simply put, t
...stry System provides high-performance detection te...c proteins and therapeutic drugs. It also delivers...ow the laboratory to streamline its operations and...esign enables numerous functions to be performed s...
The Embla 384 cell washer is a top-loading, robotic-compatible microplate washer for high throughput screening. It is designed specifically for cell-based assays, which require a gentler wash, but ca
Medicine Products: